In the study of malignant lymphoma, Kunou et al. [49] claimed that CAFs-derived exosomes induced anti-pyrimidine drug resistance via modulating the pyrimidine transporter, equilibrative nucleoside transporter 2. The gene discussed is SLC29A2; the disease is lymphoma.